10.88
Oric Pharmaceuticals Inc Azioni (ORIC) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
Revenues |
-
|
- | - | - | - |
Operating Expenses |
19.40%
39.06
|
32.72 | 39.57 | 38.32 | 36.02 |
Operating Income/Loss |
19.40%
-39.06
|
-32.72 | -39.57 | -38.32 | -36.02 |
Nonoperating Income/Loss |
0.44%
2.709
|
2.697 | 3.263 | 3.752 | 4.054 |
Income/Loss From Continuing Operations Before Tax |
21.10%
-36.35
|
-30.02 | -36.31 | -34.57 | -31.96 |
Income/Loss From Continuing Operations After Tax |
21.10%
-36.35
|
-30.02 | -36.31 | -34.57 | -31.96 |
|
21.10%
-36.35
|
-30.02 | -36.31 | -34.57 | -31.96 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
9.97%
78.13
|
71.04 | 0.3103 | 70.54 | 70.35 |
Diluted Average Shares |
9.97%
78.13
|
71.04 | 0.3103 | 70.54 | 70.35 |
Basic Earnings Per Share |
11.90%
-0.47
|
-0.42 | -0.51 | -0.49 | -0.45 |
Diluted Earnings Per Share |
11.90%
-0.47
|
-0.42 | -0.51 | -0.49 | -0.45 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):